Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation

BACKGROUND: Transplantation of oligodendrocyte precursor cells (OPCs) is an attractive therapy for demyelinating diseases. Cyclosporin A (CsA) is one of the foremost immunosuppressive agents and has widespread use in tissue and cell transplantation. However, whether CsA affects survival and differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lü, He-Zuo, Wang, Yan-Xia, Zhou, Jian-Sheng, Wang, Feng-Chao, Hu, Jian-Guo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959094/
https://www.ncbi.nlm.nih.gov/pubmed/20937147
http://dx.doi.org/10.1186/1471-2202-11-127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959094/
https://www.ncbi.nlm.nih.gov/pubmed/20937147
http://dx.doi.org/10.1186/1471-2202-11-127

Ejemplares similares